Evidence mapPaperPMID 28323912Full record

ReviewEndocrinology2017

Sex Hormones and Cardiometabolic Health: Role of Estrogen and Estrogen Receptors.

Deborah Clegg, Andrea L Hevener, Kerrie L Moreau, Eugenia Morselli, Alfredo Criollo, Rachael E Van Pelt, Victoria J Vieira-Potter

Open access · bronzeAbstract readReview
In one paragraph

Review in Endocrinology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 2 pooled it
11.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 2 syntheses or guidelines pooled it, 125 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. AdipocytesNutrients · 2018
    Trial
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Effects of dietary soy content on cerebral artery function and behavior in ovariectomized female mice.American journal of physiology. Heart and circulatory physiology · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 2 countries.

Deborah CleggDepartment of Biomedical Sciences, Diabetes and Obesity Research Institute, Cedars-Sinai Medical Center, Los Angeles, California 90048.
Andrea L HevenerDepartment of Medicine, University of California Los Angeles, Los Angeles, California 90095.
Kerrie L MoreauDivision of Geriatric Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado 80045.
Eugenia MorselliDepartment of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, 8331150, Santiago, Chile.
Alfredo CriolloAdvanced Center for Chronic Diseases and Center for Molecular Studies of the Cell, Universidad de Chile, Santiago 8380492, Chile.
Rachael E Van PeltDivision of Geriatric Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado 80045.
Victoria J Vieira-PotterDepartment of Nutrition and Exercise Physiology, University of Missouri, Columbia, Missouri 65211.
University of Colorado Anschutz Medical Campus · USCedars-Sinai Medical Center · USPontificia Universidad Católica de Chile · CLUniversity of California, Los Angeles · USUniversity of Chile · CLUniversity of Missouri · US

Funding

NIDDK NIH HHS R01 DK089109NIDDK NIH HHS R01 DK109724
6 · The paper itself

Abstract

With increased life expectancy, women will spend over three decades of life postmenopause. The menopausal transition increases susceptibility to metabolic diseases such as obesity, diabetes, cardiovascular disease, and cancer. Thus, it is more important than ever to develop effective hormonal treatment strategies to protect aging women. Understanding the role of estrogens, and their biological actions mediated by estrogen receptors (ERs), in the regulation of cardiometabolic health is of paramount importance to discover novel targeted therapeutics. In this brief review, we provide a detailed overview of the literature, from basic science findings to human clinical trial evidence, supporting a protective role of estrogens and their receptors, specifically ERα, in maintenance of cardiometabolic health. In so doing, we provide a concise mechanistic discussion of some of the major tissue-specific roles of estrogens signaling through ERα. Taken together, evidence suggests that targeted, perhaps receptor-specific, hormonal therapies can and should be used to optimize the health of women as they transition through menopause, while reducing the undesired complications that have limited the efficacy and use of traditional hormone replacement interventions.

Indexed as

Cardiovascular Physiological PhenomenaMetabolismAnimalsCardiovascular DiseasesEstrogensGonadal Steroid HormonesHumansMetabolic DiseasesReceptors, EstrogenEstrogensGonadal Steroid HormonesReceptors, Estrogen

Identifiers

PMID28323912
PMCPMC6283431
OpenAlexW2610446963

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.